semaglutide and liver damage How a drug for diabetes obesity may help heal the How a drug for diabetes

Together, these presentations reflect continued progress across the elecoglipron clinical program and its potential as a once-daily oral GLP-1 receptor agonist for people living with obesity, overweight, or type 2 diabetes

Considering coming off Ozempic cold turkey

Allodynia is a condition where normally non-painful stimuli—such as a light touch, temperature change, or even brushing your hair—cause pain

Taking a GLP-1 injection one day early is generally safe for most patients, but timing consistency matters for steady-state drug levels and side effect management

April 9, 2024 One of the first studies to attempt to treat early-stageheart failurein patients with Type 2 diabetes did not meet its primary endpoint, but a preplanned subgroup analysis found a statistically significant effect of treatment in patients who were not takingSGLT2inhibitors or GLP-1 RAs, which are antidiabetic medications that also have benefits for the heart